Covered recipient · General Payments record
ANNA PAVLOVNA JACKSON
Allopathic & Osteopathic Physicians Internal Medicine Geriatric Medicine
General Payments · PY2021–2024
$2,587.09
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,227.95 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $507.85 | 8 |
| Novo Nordisk AS | $416.94 | 9 |
| Lilly USA, LLC | $144.50 | 2 |
| Acerta Pharma LLC | $50.40 | 3 |
| IDORSIA PHARMACEUTICALS US INC | $24.93 | 1 |
| SHIELD THERAPEUTICS INC | $24.66 | 1 |
| Lundbeck LLC | $21.18 | 1 |
| Amgen Inc. | $19.86 | 1 |
| GlaxoSmithKline, LLC. | $17.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.97 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103976848 | CMS |
| ABBVIE INC. | $13.31 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103976850 | CMS |
| ABBVIE INC. | $59.71 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103976852 | CMS |
| ABBVIE INC. | $49.42 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103976854 | CMS |
| ABBVIE INC. | $69.99 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103976856 | CMS |
| ABBVIE INC. | $149.93 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103976858 | CMS |
| ABBVIE INC. | $16.99 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103976860 | CMS |
| ABBVIE INC. | $134.53 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103976862 | CMS |
| Amgen Inc. | $19.86 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117586749 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.77 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123304070 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.78 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123308384 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.85 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123308132 | CMS |
| GlaxoSmithKline, LLC. | $17.63 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116327178 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $24.93 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146770739 | CMS |
| Lilly USA, LLC | $121.84 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135557756 | CMS |
| Lilly USA, LLC | $22.66 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135518190 | CMS |
| Lundbeck LLC | $21.18 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146039463 | CMS |
| Novo Nordisk Inc | $106.15 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100312347 | CMS |
| Novo Nordisk Inc | $18.16 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100351332 | CMS |
| Novo Nordisk Inc | $14.23 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100347944 | CMS |
| Novo Nordisk Inc | $7.76 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100572416 | CMS |
| Novo Nordisk Inc | $17.98 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100271308 | CMS |
| Novo Nordisk Inc | $1.25 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100478020 | CMS |
| Novo Nordisk Inc | $19.86 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100533945 | CMS |
| Novo Nordisk Inc | $107.08 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100274578 | CMS |
| Novo Nordisk Inc | $124.47 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100328062 | CMS |
| SHIELD THERAPEUTICS INC | $24.66 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150150613 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.